The potential use of plasma NfL as a diagnostic and prognostic biomarker of fatigue in early Parkinson’s disease
Baseline plasma NfL levels may serve as a biomarker for predicting fatigue subtype conversion and the progression of fatigue in PD.
Authors
- Ning-Ning Che (ORCID: https://orcid.org/0000-0002-5470-2003)
- Tianmi Yang
- Qirui Jiang (ORCID: https://orcid.org/0000-0002-8841-7569)
- Shichan Wang (ORCID: https://orcid.org/0000-0001-5266-8748)
- Jingxuan Huang (ORCID: https://orcid.org/0009-0003-4433-7449)
- Junyu Lin (ORCID: https://orcid.org/0000-0001-5956-8301)
- Huifang Shang (ORCID: https://orcid.org/0000-0003-0947-1151)
- Jiajia Fu (ORCID: https://orcid.org/0009-0003-0436-3116)
- Yi Xiao (ORCID: https://orcid.org/0009-0005-3136-5365)
- Xueping Chen (ORCID: https://orcid.org/0000-0003-4290-7404)
- Chunyu Li
- Ruwei Ou (ORCID: https://orcid.org/0000-0002-9971-6185)
Institutions
- Sichuan University (CN)
Publication Details
- Journal
- Therapeutic Advances in Neurological Disorders
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1177/17562864251324406
- Citations
- 3
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.17
Funders
- National Key Research and Development Program of China Stem Cell and Translational Research